Fluconazole therapy in Candida albicans spondylodiscitis

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 5, 1998, Pages 527-530

  Rössel, Petra ^a,b   Schønheyder, Henrik C ^a   Nielsen, Henrik ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE;

ADULT; ARTICLE; CANDIDA ALBICANS; CASE REPORT; FEMALE; HUMAN; INTERVERTEBRAL DISK DEGENERATION; LIVER TRANSPLANTATION; LONG TERM CARE;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; DISCITIS; DRUG THERAPY, COMBINATION; FEMALE; FLUCONAZOLE; HUMANS; LIVER TRANSPLANTATION;

EID: 0032442639     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365549850161601     Document Type: Article

References (13)

1. Gathe JC Jr, Harries RL, Garland B, Bradshaw MW, Williams TW. Candida osteomyelitis. Report of five cases and review of the literature. Am J Med 1987; 82: 927-37.
2. Hillary AM. Supramolecular lipidic drug delivery systems: from laboratory to clinic. A review of the recently introduced commercial liposomal and lipid-based formulations of amphotericin B. Adv Drug Deliv Rev 1997; 24: 345-63.
3. Mehta RT, Poddar S, Kalidas M, Gomez-Flores R, Dulski K. Role of macrophages in the candidacidal activity of liposomal amphotericin B. J Infect Dis 1997; 175: 214-7.
4. Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994; 330: 263-72.
5. Grant SM, Clissold SP. Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 1990; 39: 877-916.
6. de la Torre-Lima J, Jiménez-Mejías ME, de Fransisco JL, Martin-Sanz V, Viciana Fernández JM, Cañas García-Otero E. Espondilodiscitis por Candida albicans. Med Clin (Barc) 1993; 100: 461-3.
7. Tang C. Successful treatment of Candida albicans osteomyelitis with fluconazole. J Infect 1993; 26: 89-92.
8. Mullins RF, Still JM Jr, Savage J, Davis JB, Law EJ. Osteomyelitis of the spine in a burn patient due to Candida albicans. Burns 1993; 19: 174-6.
9. Lafont A, Olivé A, Gelman M, Roca-Burniols J, Cots R, Carbonell J. Candida albicans spondylodiscitis and vertebral osteomyelitis in patients with intravenous drug addiction. Report of 3 new cases. J Rheumatol 1994; 21: 953-6.
10. Waltzing-Koudine L, Breville P, Rajzbaum G, Waltzing P. Spondylodiscite à Candida albicans. Traitement par fluconazole seul. Presse Méd 1995; 24: 505.
11. Jonnalagadda S, Veerabagu MP, Rakela J, Kusne S, Randhawa P, Rabinovitz M. Candida albicans osteomyelitis in a liver transplant recipient. Transplantation 1996; 62: 1182-4.
12. Rösler-Meier D, Brunner-La Rocca HP, Senn P, Schlumpf U. Candida-albicans-Spondylitis: erfolgreiche Behandlung mit Fluconazol. Schweiz Rundsch Med Prax 1996; 85: 520-5.
13. Hennequin C, Bourée P, Hiesse C, Dupont B, Charpentier B. Spondylodiskitis due to Candida albicans: report of two patients who were successfully treated with fluconazole and review of the literature. Clin Infect Dis 1996; 23: 176-8.